This compensatory upregulation of ZIP4 in tumour cells, driven by increased intracellular zinc demand and depletion of zinc stores, may also help explain the observed serum zinc deficiency in patients with cancer [35,37,77]. The gene discussed is SLC39A4; the disease is neoplasm.